Natco Historical Cash Flow
| NATCOPHARM | 1,492 42.10 2.90% |
Analysis of Natco Pharma cash flow over time is an excellent tool to project Natco Pharma Limited future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 9.4 B or Begin Period Cash Flow of 1.4 B as it is a great indicator of Natco Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Natco Pharma Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Natco Pharma Limited is a good buy for the upcoming year.
Natco |
About Natco Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Natco balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Natco's non-liquid assets can be easily converted into cash.
Natco Pharma Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Natco Pharma Limited to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Natco Pharma operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Natco Pharma Limited financial statement analysis. It represents the amount of money remaining after all of Natco Pharma Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Natco Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Natco Pharma Limited current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natco Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. As of now, Natco Pharma's Begin Period Cash Flow is increasing as compared to previous years. The Natco Pharma's current Depreciation is estimated to increase to about 2 B, while Stock Based Compensation is projected to decrease to 0.00.
Natco Pharma cash flow statement Correlations
Click cells to compare fundamentals
Natco Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Natco Pharma cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (289M) | (2.4B) | 564M | 191M | 424M | 445.2M | |
| Change In Cash | (85M) | 60M | 853M | 208M | 8.2B | 8.6B | |
| Stock Based Compensation | 180M | 253M | 144M | 126M | 22M | 0.0 | |
| Free Cash Flow | 587M | 442M | (2.0B) | 6.4B | 8.9B | 9.4B | |
| Change In Working Capital | (976M) | (2.1B) | (2.3B) | 627M | (3.1B) | (2.9B) | |
| Begin Period Cash Flow | 283M | 198M | 258M | 1.1B | 1.4B | 1.4B | |
| Other Cashflows From Financing Activities | 593M | (95M) | 1.2B | (2.6B) | (10.9B) | (10.4B) | |
| Depreciation | 998M | 1.2B | 1.4B | 1.6B | 1.9B | 2.0B | |
| Other Non Cash Items | (605M) | (433M) | (229M) | (2.4B) | 6.9B | 7.2B | |
| Capital Expenditures | 3.6B | 2.5B | 2.4B | 2.1B | 3.6B | 2.0B | |
| Total Cash From Operating Activities | 4.2B | 3.0B | 465M | 8.5B | 12.5B | 13.1B | |
| Net Income | 5.7B | 5.8B | 2.0B | 8.6B | 13.9B | 14.6B | |
| Total Cash From Financing Activities | (2.5B) | (1.9B) | 348M | (3.6B) | (2.3B) | (2.2B) | |
| End Period Cash Flow | 198M | 258M | 1.1B | 1.3B | 9.5B | 10.0B | |
| Sale Purchase Of Stock | (1.3B) | (1.3B) | (140M) | (74M) | (2.5B) | (2.4B) | |
| Dividends Paid | 1.5B | 1.1B | 822M | 1.0B | 1.7B | 1.8B | |
| Change To Account Receivables | (538M) | 1.3B | (2.4B) | (2.2B) | (3.4B) | (3.2B) | |
| Investments | 821M | 362M | 2.0B | (4.8B) | (10.3B) | (9.8B) | |
| Net Borrowings | (809M) | (496M) | 1.4B | (2.4B) | (2.2B) | (2.1B) | |
| Total Cashflows From Investing Activities | (1.7B) | (1.0B) | (53M) | (4.8B) | (4.3B) | (4.5B) | |
| Change To Operating Activities | (566M) | 62M | (563M) | 1.6B | 1.9B | 2.0B | |
| Other Cashflows From Investing Activities | 874M | 671M | 824M | (3.3B) | (3.0B) | (2.8B) | |
| Change To Netincome | (457M) | (461M) | (347M) | (927M) | (834.3M) | (792.6M) | |
| Change To Liabilities | 417M | (1.1B) | 74M | 1.0B | 918M | 963.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Natco Stock
The Cash Flow Statement is a financial statement that shows how changes in Natco balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Natco's non-liquid assets can be easily converted into cash.